Heart Failure Clinical Trial
Official title:
Nursing Therapeutics Education and Heart Failure (HF): an Experimental Study
Purpose: Heart Failure (HF) is a clinical multifactorial syndrome, it can cause arrhythmias
for which international guidelines suggest the implantation of an implantable cardiac
defibrillator (ICD). The educational nursing program would improve clinical outcomes in
patients with HF and ICD like control their sickness, known and acknowledge symptoms, improve
their skills to self-care.
The main aim of this study is to assess how much the nursing-therapeutics skills and an
educational intervention, in patients with HF during the follow-up period after the
implantation of ICD reduces clinical costs, re-hospitalizations, and mortality at 180 days.
Methods: The investigators start a multicenter randomized clinical trial. The sample is made
of 128 subjects (64 patients treatment group and 64 control group). The investigators
measured the self-care level administering to HF patients the "Self-Care of Heart Failure
Index (SCHFI) v. 6.2", and the self-perception of own life quality using a Numeric Rating
Scale from 0 to 100. Secondary outcomes recorded are i) the numbers of accesses to the ED
(Emergency Department) and/or hospitalizations during the follow-up period, ii) mortality
rate due to HF, and iii) infection rate of the device pocket.
Data Analysis: Categorical variables will be presented in terms of frequencies and
percentages. The statistical power was fixed at the 80%. Data will be considered significant
for a p-value ≤ 0.05. The Cox proportional hazards model will be used to analyze mortality in
subjects involved in the educational program.
Aims of the study The aim of this study is to examine the effects of a nursing intervention
consisting of sanitary-therapeutic education during the follow-up period after the
implantation of a defibrillator (ICD) in patients with congestive heart failure.
The effectiveness of the educational intervention will be assessed on the basis of the level
of "self-care" in every individual and their lifestyle as well as on mortality rates,
readmission to the hospital and ICD pocket infection.
Educational intervention will focus on
1. Appropriate lifestyles
2. Early recognition of signs/prodromal symptoms of HF
3. Early recognition of signs of inflammation of the ICD-pocket
4. Good management of the device
1. Therapy, body weight, diet, smoking, alcohol, rest, exercise, job, and sex
2. Dyspnea, edema, and fovea, rapid weight gain, loss of appetite, fatigue, asthenia,
insomnia, mental confusion
3. Signs and symptoms of inflammation: hyperpyrexia, rubor, dolor, calor and tumor
4. Identification tag, vibration, metal detectors, air travel, use of electronic devices,
diagnostic PET and MRI
Materials and methods A multicenter randomized controlled study will be performed. The
research project will involve two clinical centers in northern Italy: the "Città della
Salute e della Scienza" University Hospital of Turin, which includes the "Molinette"
Hospital (coordinator center), and the TO3 ASL, which includes the "Associated Hospitals
of Rivoli".
Subject recruitment and data collection will take place until data saturation is
achieved, with an estimated period of approximately 12 months from the beginning of the
study.
Participants
Inclusion criteria:
• Patients affected by heart failure following elective hospitalization during which an
ICD was implanted on an arrhythmic and/or ischemic basis.
• Patients who have given written consent for the research.
Exclusion criteria:
- Patients with syndromes and diseases that compromise their understanding of
information, learning and all cognitive activities in general.
- Minors.
Primary outcome measures
• Self-care levels (measured using the Self-Care Heart Failure Index, SCHFI v 6.2)
• Quality of life perception (measured using a numerical rating scale from 0 to 100)
Secondary outcome measures
• Number of visits to the ED (Emergency Department) and/or hospitalizations during the
follow-up period after the implantation of a defibrillator (ICD).
- Mortality rate at 180 days after the implantation of the ICD due to HF-related
causes.
- Infection rate in the device pocket.
Data, sources and collection tools
• Socio-demographic and clinical data: For all of the included patients, demographic
(gender, age, educational level, marital status, country of birth (Italian citizens or
foreigners), social (through a family context survey) and clinical (classification of HF
using the NYHA classification, the implantation date and type of ICD, the execution of
and the changes in laboratory tests and electrocardiograms results, number of perceived
discharges) data will be recorded. Data on the patient's diagnosis and possible
associated diseases will be obtained through the analysis of clinical documentation and
will be record in accordance with the International Statistical Classification of
Diseases and Related Health Problems, 9th Revision (ICD-IX).
• Economic data: For patients included in the study, the following data will be
collected:
• economic activity, occupational qualifications (if employed/ex-employed);
• visits to the ED and/or hospitalizations during the follow-up period, verified through
analysis of administrative documentation certifying visits and admissions (Verbal First
Aid and Medical record);
• the presence of a companion for the patients during their stay in the ED or hospital
as well as their economic activity and professional qualifications;
- any costs directly incurred by the patient or companion;
- time spent by the nursing figure in providing therapeutic education. From society's
point of view, the benefits received in the ED and hospitalizations will be
assessed according to the charge currently in force in Italy. Indirect costs,
represented by the time spent by the patient, and costs related to the time spent
by caregivers will be valorized using values published by official sources such as
ISTAT. Costs directly charged to the patient will be valued on the basis of the
stated cost. Finally, the cost of time spent in educational activities will be
assessed using the hourly average cost of a nurse and/or doctor in the clinical
centers that participate in this study.
- Self-Care Heart Failure Index (SCHFI) version 6.2. A tool validated in the Italian
context that allows evaluation of a patient's awareness and capacity for
self-care11. The obtained responses are organized on a four-level Likert scale (1 =
never, 4 = every day). Specifically, this instrument is divided into three
sections:
Section A: (questions 1 to 10) investigates self-care skills; Section B: (questions 11
to 16) investigates an individual's symptomatology recognition skills; Section C:
(questions 17 to 22) investigates the self-confidence related to self-care skills in
detail.
The total score is computed in the following manner:
Section A: 10 is subtracted from the sum of the section results considering answers 1 to
10, and the result is multiplied by a coefficient of 3.33; Section B: 4 is subtracted
from sum of the section results considering answers 11 to 16, and the result is
multiplied by a coefficient of 5; Section C: 6 is subtracted from sum of the section
results considering answers 17 to 22, and the result is multiplied by a coefficient of
5.56 All of the results have to be considered in terms of percentages. If the
percentages for individual sections are all higher than the cut-off value (70%), then
according to the literature11, the level of self-care is considered adequate. Otherwise,
for lower values, the section showing an insufficient result will be strengthened.
- Numeric Rating Scale: scale from 0 to 100 used for subjective measurement of the
perceived quality of life. This tool will be evaluated by a committee of experts using a
pre-test, which is currently under way.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05654272 -
Development of CIRC Technologies
|
||
Recruiting |
NCT05650307 -
CV Imaging of Metabolic Interventions
|
||
Recruiting |
NCT05196659 -
Collaborative Quality Improvement (C-QIP) Study
|
N/A | |
Active, not recruiting |
NCT05896904 -
Clinical Comparison of Patients With Transthyretin Cardiac Amyloidosis and Patients With Heart Failure With Reduced Ejection Fraction
|
N/A | |
Completed |
NCT05077293 -
Building Electronic Tools To Enhance and Reinforce Cardiovascular Recommendations - Heart Failure
|
||
Recruiting |
NCT05631275 -
The Role of Bioimpedance Analysis in Patients With Chronic Heart Failure and Systolic Ventricular Dysfunction
|
||
Enrolling by invitation |
NCT05564572 -
Randomized Implementation of Routine Patient-Reported Health Status Assessment Among Heart Failure Patients in Stanford Cardiology
|
N/A | |
Enrolling by invitation |
NCT05009706 -
Self-care in Older Frail Persons With Heart Failure Intervention
|
N/A | |
Recruiting |
NCT04177199 -
What is the Workload Burden Associated With Using the Triage HF+ Care Pathway?
|
||
Terminated |
NCT03615469 -
Building Strength Through Rehabilitation for Heart Failure Patients (BISTRO-STUDY)
|
N/A | |
Recruiting |
NCT06340048 -
Epicardial Injection of hiPSC-CMs to Treat Severe Chronic Ischemic Heart Failure
|
Phase 1/Phase 2 | |
Recruiting |
NCT05679713 -
Next-generation, Integrative, and Personalized Risk Assessment to Prevent Recurrent Heart Failure Events: the ORACLE Study
|
||
Completed |
NCT04254328 -
The Effectiveness of Nintendo Wii Fit and Inspiratory Muscle Training in Older Patients With Heart Failure
|
N/A | |
Completed |
NCT03549169 -
Decision Making for the Management the Symptoms in Adults of Heart Failure
|
N/A | |
Recruiting |
NCT05572814 -
Transform: Teaching, Technology, and Teams
|
N/A | |
Enrolling by invitation |
NCT05538611 -
Effect Evaluation of Chain Quality Control Management on Patients With Heart Failure
|
||
Recruiting |
NCT04262830 -
Cancer Therapy Effects on the Heart
|
||
Completed |
NCT06026683 -
Conduction System Stimulation to Avoid Left Ventricle Dysfunction
|
N/A | |
Withdrawn |
NCT03091998 -
Subcu Administration of CD-NP in Heart Failure Patients With Left Ventricular Assist Device Support
|
Phase 1 | |
Recruiting |
NCT05564689 -
Absolute Coronary Flow in Patients With Heart Failure With Reduced Ejection Fraction and Left Bundle Branch Block With Cardiac Resynchronization Therapy
|